Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × INDUSTRY × Starch × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1

Conditions

Gastrointestinal Toxicity 1

Interventions

pembrolizumab 179 Carboplatin 125 Paclitaxel 121 Gemcitabine 119 Docetaxel 94 Cyclophosphamide 89 Nivolumab 87 Cisplatin 83 Rituximab 71 Dexamethasone 65 Bevacizumab 62 Pemetrexed 61 Capecitabine 60 atezolizumab 52 Azacitidine 50 fludarabine 49 Fluorouracil 46 venetoclax 42 130-nm albumin-bound paclitaxel 42 Trastuzumab 41 Irinotecan 41 Cetuximab 38 Ipilimumab 35 Leucovorin 34 Erlotinib Hydrochloride 34 Fulvestrant 32 Cytarabine 32 avelumab 31 Albumin-Bound Paclitaxel 30 Temozolomide 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02351089 2020-03-05

ProRad

Probi AB

Phase NA Terminated

GastrointestinalGynecologic

Gastrointestinal Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡